Defining the Role of Mycophenolate Mofetil in the Treatment of Proliferative Lupus Nephritis

Author： Lenz Oliver   Fornoni Alessia   Contreras Gabriel  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.17, 2005-01, pp. : 2429-2436

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Mycophenolate Mofetil versus Cyclophosphamide for Induction Therapy of Lupus Nephritis: A Meta-Analysis of Randomized Controlled Trials

By Liu Lin-Lin  

Drugs, Vol. 72, Iss. 11, 2012-07 ,pp. : 1521-1533

Adis International

Access to resources Recommend Favorite

Treatment Options for Proliferative Lupus Nephritis: An Update of Clinical Trial Evidence

By Navaneethan Sankar D.  

Drugs, Vol. 68, Iss. 15, 2008-01 ,pp. : 2095-2104

Adis International

Access to resources Recommend Favorite

Mycophenolate mofetil a promising alternative in lupus

By  

Inpharma, Vol. 1, Iss. 1466, 2004-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Mycophenolate Mofetil for the Treatment of Systemic Sclerosis

By  

Letters in Drug Design & Discovery, Vol. 5, Iss. 2, 2008-03 ,pp. : 134-136

Bentham Science Publishers

Access to resources Recommend Favorite

Options for sequential therapy in proliferative lupus nephritis

By  

Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite